ArcticZymes Technologies ASA (OSL:AZT)
kr 13.4 -0.06 (-0.45%) Market Cap: 684.36 Mil Enterprise Value: 451.17 Mil PE Ratio: 167.50 PB Ratio: 2.15 GF Score: 69/100

ArcticZymes Technologies ASA - Special Call Transcript

Dec 15, 2020 / 07:30AM GMT
Release Date Price: kr67 (-1.47%)
Jethro Holter
ArcticZymes Technologies ASA - CEO

Okay. It's 8:30, so I suggest we start. So good morning, and welcome to the Q&A session regarding the announcement we made yesterday about divesting the Biotec BetaGlucans business to Lallemand's subsidiary, Danstar Ferment AG.

What we'd like to do today is use today to answer questions that you may have related to the announcement. We know it's some time until the Q4 announcement hence, where we thought it was timely to have a dedicated Q&A session today about the divestment.

So basically, it'd be myself, Jethro Holter, the CEO, who will answer questions and Børge would also help. Børge Sørvoll, our CFO, will also support. We'll be answering questions here as well.

But before we go into questions, I'd like to give you a little brief background about the divestment. And let's wind the clock back to December last year. It's important to understand the strategy here. So back in December last year, we made some strategic decisions. And what we said is we were going to maintain ArcticZymes Technology or Biotec Pharmacon

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot